LAKEWOOD, NJ (December 9, 2020) – Worthington, the leading supplier of specialty enzymes for over 70 years, announces today the publication of an expanded, 2021-22 Enzyme and Biochemical Product Catalog. As a primary enzyme producer for biochemistry, cell biology, molecular biology, pre-clinical research and bioprocessing applications, Worthington is the “go-to” expert in enzyme technology.
“Even with COVID restrictions in place, Worthington employees have been diligently working to support our customer’s needs, said Jim Zacka, vice president at Worthington. Releasing a number of new products this year, we continue our legacy of advancing research through innovation in enzyme development for both research, OEM and bioprocessing customers.”
The new catalog is available in two easy-to-use formats, a downloadable PDF and an easy-to-navigate, digital catalog for online browsing and purchasing.
To request a PDF, go to: Worthington-Biochem.com
About Worthington Biochemical Corporation
Founded in 1947, Worthington Biochemical Corporation is an industry leader in the development and production of high-quality purified enzymes, proteins, nucleic acids and cell isolation kits for life science research, diagnostics and biotechnology applications. An ISO9001 Certified, primary manufacturer Worthington meets enzyme requirements from research to scale-up bulk bioprocessing and OEM applications. Products extensively cited in peer-review journals and open-access publications, the company is committed to supporting STEM education. Worthington Biochemical Corporation is a privately held company, headquartered in Lakewood, NJ and has worldwide distribution through a network of exclusive distributors.
